CD11c is a protein found on the surface of certain immune cells, most famously dendritic cells, where it acts as both a molecular identification tag and a functional tool for grabbing onto other cells, pathogens, and debris. Technically, it is one half of a two-part adhesion molecule called an integrin, and it participates in everything from tissue migration to the cleanup of dead cells. While researchers initially treated CD11c as a reliable label for one cell type, the picture has grown far more complicated, with the marker turning up on macrophages, certain B cells, natural killer cells, and even brain-resident immune cells called microglia.
The Molecule Itself
CD11c is a protein chain, specifically an alpha subunit, that pairs with a partner chain called CD18 (the beta-2 subunit) to form a complete integrin known as CD11c/CD18. This complex also goes by several other names in the literature: αXβ2, p150,95, and complement receptor 4 (CR4). The pairing matters because CD11c on its own cannot function; it needs CD18 to anchor into the cell membrane and transmit signals inward when something binds on the outside.1PubMed Central. Integrin CD11c/CD18 α-chain phosphorylation is functionally important
CD11c belongs to a family of closely related leukocyte integrins that also includes CD11a, CD11b, and CD11d. All four share the same CD18 beta chain but differ in their alpha subunits, which gives each one a slightly different set of binding partners and tissue preferences. Structural analysis suggests that CD11c and CD11b arose from a gene duplication event deep in evolutionary history, and the overall architecture of these integrin genes has been remarkably conserved across species, including organisms as distant as fruit flies.2The Journal of Immunology. Structural analysis of the CD11b gene and phylogenetic analysis of the alpha-integrin gene family demonstrate remarkable conservation of genomic organization and suggest early diversification during evolution
One important detail about how CD11c works at the molecular level is its dependence on metal ions. The protein contains a region called the I-domain, and this region needs divalent cations like magnesium or manganese to grab onto its binding partners. Mutating specific amino acids in the metal-binding site dramatically reduces CD11c’s ability to latch onto fibrinogen, one of its key ligands.3PubMed. Characteristics of fibrinogen binding to the domain of CD11c, an alpha subunit of p150,95
Which Cells Carry CD11c
For years, CD11c was treated almost synonymously with dendritic cells, the immune system’s primary antigen-presenting cells. Researchers routinely used CD11c expression to identify and sort dendritic cells in mouse tissue, including gut-associated lymphoid tissue like Peyer’s patches, where CD11c-positive cells display the classic dendritic cell features: veil-like extensions, irregular nuclei, and a strong ability to stimulate T-cell responses.4PubMed. Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer’s patches That association was so strong that “CD11c-positive” became shorthand for “dendritic cell” in many experimental protocols.
The reality is messier. CD11c shows up on multiple cell types beyond dendritic cells. Macrophages, particularly tissue-resident macrophages in the lungs, express it prominently. Alveolar macrophages, the cleanup crew of the airways, are characterized by CD11c expression and are enriched in pathways related to phagosome processing, dead-cell clearance, and fatty acid metabolism.5PubMed Central. Identification and characterization of alveolar and recruited lung macrophages during acute lung inflammation Monocytes, natural killer cells, and some granulocytes also carry the marker.6Haematologica. Leukocyte CD11/CD18 integrins: biological and clinical relevance
An even more surprising finding is that certain B cells express CD11c. A subset called age-associated B cells (ABCs) is defined partly by surface CD11c, and these cells behave as memory B cells, sitting in a primed state ready to rapidly differentiate into antibody-producing plasma cells during a secondary immune response.7PubMed Central. Functional Characterization of CD11c+ Age-Associated B Cells as Memory B Cells In the brain, a proportion of microglia, the resident immune cells of the central nervous system, also express CD11c during development and in certain disease states.8PubMed Central. CD11c-expressing microglia are transient, driven by interactions with apoptotic cells This breadth of expression has gradually forced immunologists to abandon the idea that CD11c is a clean dendritic cell marker.9PubMed Central. Multifaceted, unique role of CD11c in leukocyte biology
What CD11c Actually Does
Because CD11c is an integrin, its core job is adhesion: helping cells stick to things. Those “things” include other cells, components of the extracellular matrix, and molecular debris left behind by immune responses. The integrin CD11c/CD18 binds to a range of ligands, including iC3b (a fragment of the complement system that coats pathogens and dead cells), fibrinogen (a provisional matrix protein involved in wound repair), and ICAM-1 (a cell-surface adhesion molecule found on endothelial cells lining blood vessels).10PubMed. CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity
The ability to bind endothelium is particularly relevant when immune cells need to leave the bloodstream and enter tissue at a site of infection or injury. Experiments showed that purified p150,95 (the CD11c/CD18 complex) binds directly to endothelial cells that have been activated by inflammatory signals, confirming it can function as a standalone adhesion molecule during the process of immune cell recruitment to inflamed tissue.11The Journal of Immunology. Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium
CD11c also plays a role in clearing dead cells, a process called efferocytosis. When cells die by apoptosis, complement proteins tag their surfaces with iC3b, and phagocytes expressing CD11c/CD18 recognize and engulf the tagged remains.12Anais da Academia Brasileira de Ciências. Apoptotic cell and phagocyte interplay: recognition and consequences in different cell systems Blocking studies on human dendritic cells have confirmed that CD11c contributes to the uptake of both apoptotic and necrotic material, though it works alongside other receptors like CD36 rather than handling the job alone.13Journal of Leukocyte Biology. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets
CD11c and Antigen Presentation
Beyond simple adhesion and cleanup, CD11c has a more active role in shaping immune responses through antigen presentation. Dendritic cells are the primary bridge between the innate immune system (which responds to threats immediately but non-specifically) and the adaptive immune system (which generates targeted antibodies and killer T cells). For dendritic cells to prime T cells against a specific threat, they first need to capture material from that threat and process it into small fragments that can be displayed on their surface.
CD11c is directly involved in this capture step. In mice engineered to lack functional CD11c on their dendritic cells, the ability to capture and process cell-associated antigens was severely impaired, and the resulting T-cell proliferation and differentiation were both defective.14PubMed Central. Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity Similarly, depleting CD11c-positive dendritic cells entirely abolished a specific arm of the immune response called cross-priming, in which dendritic cells present material from other cells to CD8-positive killer T cells.15Immunity. In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens Without this process, the adaptive immune system has a much harder time mounting an effective response against infections and tumors that rely on T-cell-mediated killing.
A Role in Immune Tolerance
The immune system must strike a balance between attacking genuine threats and leaving the body’s own tissues alone. CD11c-positive dendritic cells are involved on both sides of that balance. A specific subset co-expressing CD11c and CD11b was found to accumulate in the central nervous systems of mice made tolerant to an autoimmune trigger. These cells produced high levels of the anti-inflammatory molecules IL-10 and TGF-beta while producing less of the pro-inflammatory signal IL-12. When cultured with T cells, they suppressed the expansion of self-reactive T cells and promoted the generation of regulatory T cells, which actively keep the immune system in check.16PubMed Central. CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis
When these tolerogenic dendritic cells were adoptively transferred into mice with ongoing experimental autoimmune disease of the brain and spinal cord, they significantly suppressed the disease. This finding has generated interest in whether CD11c-positive tolerogenic dendritic cells could eventually be used as a cell-based therapy for autoimmune conditions, though that work remains in early stages.
CD11c Expression Changes with Activation
One wrinkle that has caused headaches for experimentalists is that CD11c levels are not static. In mice, dendritic cells actually downregulate CD11c when they become activated through Toll-like receptor signaling, the pathway triggered by bacterial and viral products.17PubMed. The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering This means that the very cells you might want to study most, dendritic cells that are actively responding to an infection, can become harder to find using CD11c as your search criterion. Researchers who rely on CD11c-high as a gating strategy in flow cytometry may inadvertently exclude the most immunologically active dendritic cells from their analyses.
This dynamic expression partly explains why CD11c-driven transgenic tools, while hugely valuable, have been dogged by specificity problems. Mouse strains engineered so that a gene of interest turns on wherever CD11c is expressed tend to affect not just dendritic cells but also macrophages, some NK cells, and activated T cells. A critical review of these tools concluded that no commonly used myeloid-specific promoter, including the CD11c promoter, provides truly reliable differential expression in any single myeloid cell subset.18Journal of Leukocyte Biology. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity The tools remain useful for imaging and genomics, but the specificity claims around them have historically been overstated.
CD11c in Obesity and Metabolic Disease
Fat tissue is not just a storage depot; it is an active immunological organ, and CD11c has emerged as an important marker in the inflammatory processes that link obesity to insulin resistance. In obese individuals, a population of macrophages in adipose tissue that express CD11c alongside the marker CD206 is associated with impaired insulin signaling. When researchers collected conditioned media from these CD11c-positive adipose tissue macrophages and exposed human fat cells to it, the fat cells took up less glucose in response to insulin. Media from CD11c-negative macrophages or other tissue cells had no such effect.19PubMed Central. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity
Animal studies reinforce the connection. In mice fed a high-fat diet, CD11c levels on blood monocytes and in adipose tissue correlated with insulin resistance. Mice genetically lacking CD11c gained the same amount of weight on a high-fat diet as normal mice but showed less tissue inflammation, fewer T cells infiltrating their fat, lower levels of inflammatory chemokines, and better insulin sensitivity and glucose tolerance.20PubMed Central. CD11c expression in adipose tissue and blood and its role in diet-induced obesity The weight gain was the same, but the metabolic consequences were milder, suggesting that CD11c-expressing immune cells are active participants in turning obesity into metabolic disease, not just bystanders.
CD11c-Positive B Cells in Autoimmune Disease
The CD11c-positive age-associated B cells mentioned earlier are not just an aging curiosity. They have attracted intense interest in autoimmune disease research, particularly in lupus. Deep phenotyping of peripheral blood B cells in patients with systemic lupus erythematosus (SLE) revealed a significantly higher frequency of CD11c-positive B cells compared to healthy donors. A similar but more modest increase was seen in primary Sjögren’s syndrome.21PubMed Central. Deep Phenotyping of CD11c + B Cells in Systemic Autoimmunity and Controls
These cells are also proving stubbornly difficult to eliminate with existing therapies. In mouse models of lupus, T-bet-positive CD11c-positive age-associated B cells resisted ablation strategies targeting either the B-cell survival factor BLyS or the CD20 surface protein, both of which are the basis of current biologic therapies for autoimmune disease.22PubMed. T-bet(+)CD11c(+) age-associated B cells resist BLyS- and CD20-targeted ablation in murine lupus models If these findings translate to humans, they could help explain why some lupus patients respond poorly to rituximab and belimumab, and they point toward the need for new strategies that specifically target this resistant B cell population.
CD11c in Cancer Diagnostics
Outside of basic immunology, CD11c has a practical clinical role in the diagnosis of certain blood cancers. Hairy cell leukemia (HCL), a rare B-cell malignancy, characteristically shows bright CD11c expression on its tumor cells. In flow cytometry panels, CD11c is part of a scoring system used alongside CD25, CD103, and CD123 to distinguish classic HCL from look-alike conditions such as hairy cell leukemia variant (HCL-v) and splenic marginal zone lymphoma (SMZL).23PubMed Central. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria
Classic HCL expresses bright CD11c, bright CD25, CD103, and bright homogeneous CD123. HCL variant, by contrast, expresses CD11c and CD103 but typically lacks CD25 and shows dim or absent CD123. The distinction matters because HCL-v responds poorly to the standard HCL therapy (cladribine) and requires different treatment approaches. Newer work has explored adding CD26 to this panel, which improved the specificity of the diagnostic scoring system to 100% while maintaining perfect sensitivity for identifying classic HCL.24PubMed Central. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
CD11c-Expressing Microglia in the Brain
Microglia are the brain’s resident immune cells, and a subset of them transiently expresses CD11c during specific developmental windows and disease contexts. In the developing retina, a significant proportion of microglia become CD11c-positive, and similar observations have been made in neurodegenerative disease models.8PubMed Central. CD11c-expressing microglia are transient, driven by interactions with apoptotic cells Recent work suggests these CD11c-positive microglia are a temporary state rather than a distinct lineage, driven by encounters with apoptotic cells. During brain development, large numbers of neurons are pruned through programmed cell death, and the microglia tasked with cleaning up the debris appear to upregulate CD11c as part of that response.
This transient expression adds another layer of complexity to interpreting CD11c in tissue sections. A brain tissue sample showing CD11c-positive cells is not necessarily infiltrated by dendritic cells from the periphery; the cells may be resident microglia in a specific activation state. Distinguishing between the two requires additional markers and context, a recurring theme with CD11c.
Why CD11c Is Not a Perfect Marker for Anything
If there is a through line in CD11c research over the past two decades, it is the gradual realization that equating a surface marker with a cell identity leads to trouble. Early studies confidently used CD11c to define dendritic cells, but the marker appears on macrophages in every tissue, on specialized B cells, on NK cells, and on microglia. It goes down when dendritic cells activate and up when microglia encounter dying neurons. Transgenic mice built on the CD11c promoter affect more cell types than intended.18Journal of Leukocyte Biology. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity
Modern immunology increasingly relies on panels of multiple markers, single-cell RNA sequencing, and functional assays rather than any single surface protein to classify cells. CD11c remains a useful part of that toolkit, but researchers who interpret it in isolation risk misidentifying which cells they are actually looking at. For anyone reading immunology papers, the lesson is that “CD11c-positive cell” should not be silently translated to “dendritic cell” without checking what other markers were measured alongside it.